We are live on ! Find out more
IC

Intersect Capital Portfolio holdings

AUM $331M
1-Year Est. Return 6.79%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
-6.79%
3 Year Est. Return
+57.23%
5 Year Est. Return
+88.96%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$18.8M
Cap. Flow
+$19.8M
Cap. Flow %
3.38%
Top 10 Hldgs %
37.18%
Holding
424
New
49
Increased
206
Reduced
105
Closed
21
Avg Time Held Equity + Options
7.9 quarters
Top 10 Avg Time Held Equity + Options
14.3 quarters
Top 20 Avg Time Held Equity + Options
15.2 quarters
Avg Time Held Equity only
8 quarters
Top 10 Avg Time Held Equity only
14.3 quarters
Top 20 Avg Time Held Equity only
15.2 quarters

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.42M
2
DFAT icon
U.S. Targeted Value Portfolio ETF Class Shares
DFAT
+$1.08M
3
T icon
AT&T
T
+$827K
4
CSCO icon
Cisco
CSCO
+$608K
5
GM icon
General Motors
GM
+$558K

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.4%
2 Technology 22.08%
3 Financials 7.51%
4 Healthcare 7.2%
5 Consumer Discretionary 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DHC icon
401
Diversified Healthcare Trust
DHC
$1.85B
$80K 0.01%
23,690
+4,914
+26% +$18.5K
2020 Q4
3 quarters
DFTX icon
402
Definium Therapeutics
DFTX
$4.62B
$76K 0.01%
2,167
– –
2021 Q2
1 quarter
CHPT icon
403
ChargePoint
CHPT
$194M
$6K ﹤0.01%
15
– –
2021 Q2
1 quarter
APTV icon
404
Aptiv
APTV
$9.19B
– –
-1,297
Closed -$204K –
AVT icon
405
Avnet
AVT
$8.19B
– –
-5,265
Closed -$211K –
CL icon
406
Colgate-Palmolive
CL
$71.7B
– –
-2,524
Closed -$205K –
CRBP icon
407
Corbus Pharmaceuticals
CRBP
$92.5M
– –
-484
Closed -$27K –
EAF icon
408
GrafTech
EAF
$214M
– –
-1,124
Closed -$131K –
EAT icon
409
Brinker International
EAT
$8.47B
– –
-3,939
Closed -$244K –
GM icon
410
General Motors
GM
$73.7B
– –
-9,438
Closed -$558K –
HNI icon
411
HNI Corp
HNI
$3.44B
– –
-5,210
Closed -$229K –
NIO icon
412
NIO
NIO
$8.92B
– –
-5,029
Closed -$268K –
PH icon
413
Parker-Hannifin
PH
$120B
– –
-705
Closed -$216K –
FLNA icon
414
CALL
Filana Therapeutics
FLNA
$35.9M
– –
-4,200
Closed -$359K –
FLNA icon
415
Filana Therapeutics
FLNA
$35.9M
– –
-2,252
Closed -$192K –
TKR icon
416
Timken Company
TKR
$7.92B
– –
-3,857
Closed -$311K –
USNA icon
417
Usana Health Sciences
USNA
$286M
– –
-1,957
Closed -$200K –
WU icon
418
Western Union
WU
$1.9B
– –
-12,321
Closed -$283K –
GAP icon
419
The Gap Inc
GAP
$8.02B
– –
-5,931
Closed -$200K –
QVCGA
420
DELISTED
QVC Group Inc Series A
QVCGA
– –
-292
Closed -$191K –
WRK icon
421
DELISTED
WestRock Company
WRK
– –
-3,993
Closed -$213K –
SYKE
422
DELISTED
SYKES Enterprises Inc
SYKE
– –
-3,776
Closed -$203K –
WPF.U
423
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
– –
-22,428
Closed -$235K –
ATVI
424
DELISTED
Activision Blizzard
ATVI
– –
-3,263
Closed -$311K –

Similar funds

Intersect Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Intersect Capital held 424 positions worth $585M, up 3.3% from $566M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Intersect Capital deployed $19.8M of net new capital in Q3 2021, opening 49 new positions and adding to 206 existing holdings. Its largest new stake was Snap: 28,810 shares worth $2.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 36% of assets, down from 37% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $1.42M trimmed.

  • Intersect Capital's largest Q3 2021 buy was Snap: 28,810 shares worth $2.13M.
  • Intersect Capital added most to Eaton Vance Senior Floating-Rate Fund in Q3 2021, an estimated $1.27M increase.
  • Intersect Capital's biggest Q3 2021 reduction was Apple, cutting an estimated $1.42M.
  • Intersect Capital fully exited General Motors in Q3 2021, selling an estimated $558K.
  • Intersect Capital's ten largest holdings make up 37% of its $585M portfolio in Q3 2021.
  • Intersect Capital opened 49 new positions and closed 21 in Q3 2021.
  • Intersect Capital's portfolio value rose 3.3% quarter-over-quarter to $585M.

Based on Intersect Capital's 13F filing for Q3 2021, filed 15 Oct 2021.